Your browser doesn't support javascript.
loading
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.
Lancet Infect Dis ; 12(9): 671-7, 2012 Sep.
Article in En | MEDLINE | ID: mdl-22714001

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepacivirus / Hepatitis C, Chronic / Imidazoles Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Europa Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2012 Document type: Article Affiliation country: France Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepacivirus / Hepatitis C, Chronic / Imidazoles Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Europa Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2012 Document type: Article Affiliation country: France Country of publication: United States